Filing Details

Accession Number:
0001209191-17-064399
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-07 16:05:36
Reporting Period:
2017-12-05
Accepted Time:
2017-12-07 16:05:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585017 Jason Ryan 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-05 3,038 $0.08 55,639 No 4 M Direct
Common Stock Disposition 2017-12-05 3,038 $61.26 52,601 No 4 S Direct
Common Stock Acquisiton 2017-12-05 18,688 $7.12 71,289 No 4 M Direct
Common Stock Disposition 2017-12-05 18,688 $61.26 52,601 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Disposition 2017-12-05 3,038 $0.00 3,038 $0.08
Common Stock stock option (right to buy) Disposition 2017-12-05 18,688 $0.00 18,688 $7.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-06-15 No 4 M Direct
1,562 2023-05-21 No 4 M Direct
Footnotes
  1. The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.35 to $62.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  2. This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vested in equal quarterly installments until fully vested on May 16, 2015.
  3. This option was granted on May 21, 2013 and vests in equal quarterly installments beginning on April 1, 2014 until fully vested on January 1, 2018.